Identification of novel HIV 1--protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening

Item

http://www.wikidata.org/entity/Q28485115

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Identification of novel HIV 1- ...... mapping and virtual screening

@ast

Identification of novel HIV 1- ...... mapping and virtual screening

@en

Identification of novel HIV 1- ...... mapping and virtual screening

@nl

type

Item

label

Identification of novel HIV 1- ...... mapping and virtual screening

@ast

Identification of novel HIV 1- ...... mapping and virtual screening

@en

Identification of novel HIV 1- ...... mapping and virtual screening

@nl

prefLabel

Identification of novel HIV 1- ...... mapping and virtual screening

@ast

Identification of novel HIV 1- ...... mapping and virtual screening

@en

Identification of novel HIV 1- ...... mapping and virtual screening

@nl

P1476

Identification of novel HIV 1- ...... mapping and virtual screening

@en

P2093

Divya Yadav

http://www.w3.org/2001/XMLSchema#string

Mahima Pal

http://www.w3.org/2001/XMLSchema#string

Sarvesh Paliwal

http://www.w3.org/2001/XMLSchema#string

P2860

Design and Synthesis of HIV-1 Protease Inhibitors Incorporating Oxazolidinones as P2/P2‘ Ligands in Pseudosymmetric Dipeptide Isosteres

Design, synthesis, and X-ray crystallographic analysis of a novel class of HIV-1 protease inhibitors

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.

Targeting the HIV-protease in AIDS therapy: a current clinical perspective.

Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors.

P304

e48942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0048942

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rakesh Yadav

Anubhuti Pandey

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233397161

http://www.w3.org/2001/XMLSchema#string

P698

23145032

http://www.w3.org/2001/XMLSchema#string

P932

3493599

http://www.w3.org/2001/XMLSchema#string